Acute Myeloid Leukemia Clinical Trial

Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy

Summary

This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults (ages 18 - 99 years) undergoing inpatient intensive chemotherapy for newly diagnosed, refractory, or relapsed AML. Patients may or may not have been exposed to any type of therapy before.
Any intensive chemotherapy regimen defined as a planned ~4 week inpatient stay. Chemotherapy may be delivered for any number of days and on any schedule. Patients may be discharged from the hospital sooner than 4 weeks if the treating physician choose so, but the expectation at the initiation of chemotherapy must be ~4 weeks of inpatient stay, as is typical.
Able to provide written voluntary consent before performance of any study related procedure.

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

54

Study ID:

NCT03728699

Recruitment Status:

Active, not recruiting

Sponsor:

Masonic Cancer Center, University of Minnesota

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Masonic Cancer Center at University of Minnesota
Minneapolis Minnesota, 55455, United States

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Estimated Enrollment:

54

Study ID:

NCT03728699

Recruitment Status:

Active, not recruiting

Sponsor:


Masonic Cancer Center, University of Minnesota

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.